The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma

PURPOSE OF REVIEW: Multiple myeloma (MM) is a hematologic malignancy of plasma cells that remains incurable with currently available therapies including proteosome inhibitors, immunomodulators, monoclonal antibodies, corticosteroids, and alkylators, in addition to autologous stem cell transplantatio...

Descripción completa

Detalles Bibliográficos
Autores principales: McCurdy, Arleigh, Visram, Alissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Multiple Myeloma (Prashant Kapoor, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684923/
https://www.ncbi.nlm.nih.gov/pubmed/36417082
http://dx.doi.org/10.1007/s11899-022-00682-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684923/
https://www.ncbi.nlm.nih.gov/pubmed/36417082
http://dx.doi.org/10.1007/s11899-022-00682-4

Ejemplares similares